본 서비스에서 제공하는 사용자의 개인정보 데이터를 포함하여 각 정보주체의 동의 없이 데이터를 무단으로 수집하는 행위를 금지 및 거부합니다. 공개된 데이터도 크롤링 등 기술적 장치를 이용해 허가 없이 수집하는 경우 개인정보 보호법에 따라 형사처벌 될 수 있음을 알려드립니다.
© 2025 Rocketpunch, 주식회사 더블에이스, 홍원표, 대한민국 서울특별시 성동구 성수일로10길 12, 12층 1호, 04793, support@rocketpunch.com, +82 10-2710-7121
사업자등록번호 206-87-09615
더보기


김성진
Qualitifed capability in brand management and business development through wide collaboration and well trained in big global company about not only system, operation, but also collabotion and value.
커리어
게시물
경력
AsiaPacifi Marketing Lead for Urology In charge of all Asia Pacific countries including Chian, Japan, Taiwan, Austrailia etc for Urology pipeline. Marketing Manager, Urology • In charge of all the commercial initiatives of Urology (10 bil KRW annual sales from 2 brands, anti-diuretic and anti-prostate cancer), Business Development for new pipeline and alliance with managing 1 product managers. • Initiated revitalization projects for the legacy brand MINIRIN with integrated campaign across public to physician directly and developed innovative satellite program with APAC countries under academic society endorsement. • Started to drive new business with FIRMAGON under tough situation due to reimbursement criteria through close collaboration with market access team and KOLs. • Explored new opportunity through business development; developed business cases for TESTAVAN (topical testosterone) and CONDOLIASE (Lumber Disc Herniation). • BD initiatives including urology clinic co-promotion to expand sales presence to induce the sales increase for untapped channels and evolving business model with new partner.
더보기
• Business development of CONNECTA for connecting art work by artist and affordable buyers and developing digital showroom of exhibition for audience who want to enjoy artwork, but physically cannot visit. • Business development for KNOWHOW Of SENIOR for connecting deficiency from young business man for work skill by industry and by specialties such as marketing, finance, HR, sales to surplus from senior who has validated capability and accumulated experience in specialty. • Published book named “Reality of Multinational Company” in Dec 2017. • Published e-book named “Future seizing: Journey to Death” in Sep 2018.
더보기
Marketing Manager, CV-GI Business Unit (Feb~Sep 2016) • In charge of Crestor® (rosuvastatin), Atacand® (Candesartan), Nexium® (Esomeprazole) commercial activities in the key specialties (CV, GI, ENDO, IM, and FM) of Top 130 General Hospitals directly and the Clinic sector with co-promotion partner Daewoong and Green Cross, managing 1 brand managers/2 associates. • Covered 143.0 bil KRW by securing market competitiveness as SoV 1 or 2 even after loss of exclusivity with strong alliance management to regain market share. • Led the Business Unit with 60 sales reps successfully for 4 months during BU head vacancy. Brand Manager, RG Business Unit (Oct.2011~Jan.2016) • Led launch preparation processes of VIMOVO® (naproxen+esomeprazole) with leading New Product Launch TFT as a leader from regulatory, pricing, quality assurance, and supply chain management to the commercial readiness to acquire Nov 2011 launch approval by the AZ Global Team and launch Aug 2012. • Achieved 110.8% of sales target of VIMOVO with No.1 SoV and SoFNB under successful collaboration with alliance partner, LG Life Science. • Led Nexium to No.1 M/S in PPI market from 2013 with 44.2 bil KRW, 33.2% G/R through reinforcing co-promotion with Daewoong backed up by integrated marketing campaign named “GERD Awareness Campaign” • Secured No.1 position of Nexium with 52.6 bil KRW, 34.3% g/r in 2014 through leveraging scientific programs such as Korean-AP summit and Int’l speaker programs even after loss of exclusivity and fierce competition with 25 generics. Clinical Research Manager (Oct 2007~ Sep 2011) • Managed primary care pipelines including CV/Endo/Res/GI with leading 6 team members. • Handled CROs and developed clinical operating SOPs and followed global audit. Clinical Project Leader • Managed major clinical project teams for Brillinta (antiplatelet), Onglyza (DDP-IV), Symbicort (Inhaler), Forxiga (SGLT-2), Crestor (Statin). Atacand (ARB), Seroquel (Anti-psychotic) and Ceftaroline (Anti-inflammation) successfully to deliver all timeline and allocated target number through close collaboration with project team and global affiliates. Received the “Diamond Award” in 2014 and Top Performer in 2015 at AstraZeneca Korea, educated for Seoul Nation University MBA program for 6 months in 2011, and attended marketing college by AstraZeneca AP in 2013, trained various programs such as Coaching in transition(2016), Leadership selling(2015), Logical thinking(2014), communication skill as marketer(2013), People management skill(2011), negotiation skill(2009).
더보기
Research Scientist, AG CnTech Laboratories • Initiated the development of ANYCOUGH(Antitussive, Asthma) from pre-clinical study design and clinical study from phase I to phase III with CRO and KOLs and communicated directly KFDA officer to develop fundamental design, dosage and indication for IND and NDA. • Developed lots of business development for in-licensing of medical device(needles injector), asthma patch and out-licensing existing pipeline through attending EuroPLX 2007 at Cyprus.
더보기
언어
중급 (업무상 의사소통)
이 프로필의 소유자이신가요?
인증을 통해 현재 프로필에 병합하거나 삭제할 수 있습니다. 만약 인증할 수 없는 경우 본인임을 증빙하는 서류 제출 후 프로필 관리 권한을 취득할 수 있습니다.